Posts

A Korean Hospital’s AI Blood Test Points to a Less Invasive Future for Colon Cancer Screening — and Raises Big Questions for the U.S.

0

South Korea’s Lunit Is Selling Medical AI to the World. Now It Has to Prove It Can Turn Growth Into Profit.

0

Prostate Cancer Becomes the Most Common Cancer Among Men in South Korea, Reflecting a Broader Shift in Aging and Prevention

0